Northwestern University-Feinberg School of Medicine, Department of Neurology, United States; Northwestern University-Feinberg School of Medicine, Department of Surgery, Division of Organ Transplantation, United States; Northwestern University Transplant Outcomes Research Collaboration, United States.
Harvard Medical School, Department of Neurology, United States.
Neurosci Lett. 2020 Mar 16;721:134818. doi: 10.1016/j.neulet.2020.134818. Epub 2020 Feb 5.
Liver disease is a growing public health concern. Hepatic encephalopathy, the syndrome of brain dysfunction secondary to liver disease, is a frequent complication of both acute and chronic liver disease and cerebral edema (CE) is a key feature. While altered ammonia metabolism is a key contributor to hepatic encephalopathy and CE in liver disease, there is a growing appreciation that additional mechanisms contribute to CE. In this review we will begin by presenting three classic perspectives that form a foundation for a discussion of CE in liver disease: 1) CE is unique to acute liver failure, 2) CE in liver disease is only cytotoxic, and 3) CE in liver disease is primarily an osmotically mediated consequence of ammonia and glutamine metabolism. We will present each classic perspective along with more recent observations that call in to question that classic perspective. After highlighting these areas of debate, we will explore the leading contemporary mechanisms hypothesized to contribute to CE during liver disease.
肝脏疾病是一个日益严重的公共卫生问题。肝性脑病是一种由于肝脏疾病引起的大脑功能障碍综合征,是急性和慢性肝脏疾病的常见并发症,脑水肿(CE)是其主要特征。虽然氨代谢的改变是肝性脑病和 CE 的一个关键因素,但越来越多的人认识到其他机制也对 CE 有贡献。在这篇综述中,我们将首先提出三个经典观点,为讨论肝脏疾病中的 CE 奠定基础:1)CE 是急性肝衰竭所特有的,2)肝脏疾病中的 CE 仅具有细胞毒性,3)肝脏疾病中的 CE 主要是氨和谷氨酰胺代谢的渗透压介导的结果。我们将提出每个经典观点,以及最近的观察结果,这些结果对该经典观点提出了质疑。在强调这些争议领域之后,我们将探讨在肝脏疾病中假设有助于 CE 的主要当代机制。